+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Doxorubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Formulation, Application, and Distribution Channel - Product Thumbnail Image

Doxorubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Formulation, Application, and Distribution Channel

  • Report
  • July 2022
  • 199 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class and Distribution Channel - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug Class and Distribution Channel

  • Report
  • May 2022
  • 151 Pages
  • Global
From
Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application , and End User, and Geography - Product Thumbnail Image

Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin, Dalteparin, Tinzaparin, Fraxiparine, Nadroparin, and Others), Packaging (Multi-Vials and Prefilled Syringes), Application , and End User, and Geography

  • Report
  • December 2021
  • 191 Pages
  • Global
From
Cancer Gene Therapy Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034 - Product Thumbnail Image

Cancer Gene Therapy Market Outlook Report: Industry Size, Market Shares Data, Latest Trends, Insights, Growth Potential, CAGR Forecasts to 2034

  • Report
  • December 2024
  • 150 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • December 2024
  • 1394 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Competitive Landscape - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Competitive Landscape

  • Report
  • December 2023
  • 75 Pages
  • Global
From
Anal Cancer (AC) - Competitive Landscape - Product Thumbnail Image

Anal Cancer (AC) - Competitive Landscape

  • Report
  • December 2023
  • 77 Pages
  • Global
From
Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Artificial Pancreas Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 121 Pages
  • Global
From
IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

IgA Nephropathy (Berger's Disease) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 72 Pages
  • Global
From
Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Diffuse Large B-Cell Lymphoma (DLBCL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • August 2023
  • 111 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Non-Small Cell Lung Cancer (NSCLC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 33 Pages
  • Global
From
Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • February 2023
  • 35 Pages
  • Global
From
Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Bladder Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 97 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Bile Duct Cancer (Cholangiocarcinoma) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • November 2022
  • 82 Pages
  • Global
From
Cervical Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Cervical Cancer - Epidemiology Forecast to 2030

  • Report
  • January 2022
  • 41 Pages
  • Global
From
Brain Cancer - Epidemiology Forecast to 2030 - Product Thumbnail Image

Brain Cancer - Epidemiology Forecast to 2030

  • Report
  • December 2021
  • 42 Pages
  • Global
From
Prostate Cancer: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • Report
  • August 2019
  • 212 Pages
  • Global
From
Ovarian Cancer: Epidemiology Forecast to 2028 - Product Thumbnail Image

Ovarian Cancer: Epidemiology Forecast to 2028

  • Report
  • July 2019
  • 46 Pages
  • Global
From
Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Multiple Myeloma: Global Drug Forecast and Market Analysis to 2027

  • Report
  • March 2019
  • 164 Pages
  • Global
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more